© Drug Hunter Inc. 2018-2023
Home > MLT-985
allosteric MALT1 protease (paracaspase) inh.
oral QD act. in xenograft; on-target pathology
from 1M cmpd biochem. HTS and opt.
J. Med. Chem., Nov. 20, 2020
Novartis, Basel, CH
MLT-985 (Novartis allosteric MALT1 protease (paracaspase) inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year